Handelsbanken Fonder AB / GILD
Handelsbanken Fonder AB’s Gilead Sciences Inc Position
Does Handelsbanken Fonder AB own Gilead Sciences Inc (GILD)? Yes — 1.05M shares worth $147M (+0.49% of its 13F portfolio) as of Q1 2026, down from 1.07M shares the prior filed quarter.
Position Value
$147M
Q1 2026
Shares
1.05M
% of Portfolio
+0.49%
Quarters Held
26
currently held
Position History GILD
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 1.05M | $147M | +0.49% |
| Q4 2025 | 1.07M | $131M | +0.40% |
| Q3 2025 | 1.15M | $128M | +0.41% |
| Q2 2025 | 1.16M | $129M | +0.46% |
| Q1 2025 | 1.09M | $123M | +0.51% |
| Q4 2024 | 590.2K | $55M | +0.21% |
| Q3 2024 | 538.7K | $45M | +0.18% |
| Q2 2024 | 549.4K | $38M | +0.16% |
| Q1 2024 | 499.0K | $37M | +0.16% |
| Q4 2023 | 572.2K | $46M | +0.23% |
| Q3 2023 | 561.8K | $42M | +0.24% |
| Q2 2023 | 576.1K | $44M | +0.24% |
| Q1 2023 | 651.1K | $54M | +0.31% |
| Q4 2022 | 633.9K | $54M | +0.34% |
| Q3 2022 | 488.0K | $30M | +0.20% |
| Q2 2022 | 427.5K | $26M | +0.17% |
| Q1 2022 | 329.5K | $20M | +0.11% |
| Q4 2021 | 312.5K | $23M | +0.11% |
| Q3 2021 | 323.8K | $23M | +0.12% |
| Q2 2021 | 323.4K | $22M | +0.12% |
| Q1 2021 | 309.5K | $20M | +0.11% |
| Q4 2020 | 357.1K | $21M | +0.13% |
| Q3 2020 | 296.5K | $19M | +0.14% |
| Q2 2020 | 577.5K | $44M | +0.19% |
| Q2 2019 | 99.2K | $7M | +0.12% |
| Q1 2019 | 168.7K | $11M | +0.21% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Handelsbanken Fonder AB’s full portfolio or all institutional holders of GILD.